Logo image of POCI

PRECISION OPTICS CORP INC (POCI) Stock Fundamental Analysis

NASDAQ:POCI - Nasdaq - US7402944000 - Common Stock - Currency: USD

4.25  +0.02 (+0.47%)

After market: 4.05 -0.2 (-4.71%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to POCI. POCI was compared to 189 industry peers in the Health Care Equipment & Supplies industry. POCI may be in some trouble as it scores bad on both profitability and health. POCI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year POCI has reported negative net income.
POCI had a negative operating cash flow in the past year.
In the past 5 years POCI always reported negative net income.
In the past 5 years POCI reported 4 times negative operating cash flow.
POCI Yearly Net Income VS EBIT VS OCF VS FCFPOCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M

1.2 Ratios

The Return On Assets of POCI (-22.90%) is comparable to the rest of the industry.
POCI's Return On Equity of -42.31% is in line compared to the rest of the industry. POCI outperforms 52.91% of its industry peers.
Industry RankSector Rank
ROA -22.9%
ROE -42.31%
ROIC N/A
ROA(3y)-7.91%
ROA(5y)-9.57%
ROE(3y)-13.61%
ROE(5y)-19.08%
ROIC(3y)N/A
ROIC(5y)N/A
POCI Yearly ROA, ROE, ROICPOCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

POCI has a Gross Margin of 27.14%. This is in the lower half of the industry: POCI underperforms 76.72% of its industry peers.
POCI's Gross Margin has been stable in the last couple of years.
POCI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.9%
GM growth 5Y-0.54%
POCI Yearly Profit, Operating, Gross MarginsPOCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

1

2. Health

2.1 Basic Checks

POCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
POCI has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for POCI has been increased compared to 5 years ago.
Compared to 1 year ago, POCI has a worse debt to assets ratio.
POCI Yearly Shares OutstandingPOCI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
POCI Yearly Total Debt VS Total AssetsPOCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -1.39, we must say that POCI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of POCI (-1.39) is worse than 61.90% of its industry peers.
A Debt/Equity ratio of 0.27 indicates that POCI is not too dependend on debt financing.
POCI's Debt to Equity ratio of 0.27 is in line compared to the rest of the industry. POCI outperforms 51.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z -1.39
ROIC/WACCN/A
WACC8.72%
POCI Yearly LT Debt VS Equity VS FCFPOCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

POCI has a Current Ratio of 1.22. This is a normal value and indicates that POCI is financially healthy and should not expect problems in meeting its short term obligations.
POCI's Current ratio of 1.22 is on the low side compared to the rest of the industry. POCI is outperformed by 83.07% of its industry peers.
POCI has a Quick Ratio of 1.22. This is a bad value and indicates that POCI is not financially healthy enough and could expect problems in meeting its short term obligations.
POCI has a worse Quick ratio (0.62) than 89.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.62
POCI Yearly Current Assets VS Current LiabilitesPOCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for POCI have decreased strongly by -48.84% in the last year.
The Revenue has decreased by -2.77% in the past year.
Measured over the past years, POCI shows a very strong growth in Revenue. The Revenue has been growing by 22.95% on average per year.
EPS 1Y (TTM)-48.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.38%
Revenue 1Y (TTM)-2.77%
Revenue growth 3Y21.43%
Revenue growth 5Y22.95%
Sales Q2Q%-6.02%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
POCI Yearly Revenue VS EstimatesPOCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
POCI Yearly EPS VS EstimatesPOCI Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 -0.1 -0.2 -0.3 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for POCI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
POCI Price Earnings VS Forward Price EarningsPOCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
POCI Per share dataPOCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

POCI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PRECISION OPTICS CORP INC

NASDAQ:POCI (4/29/2025, 8:00:01 PM)

After market: 4.05 -0.2 (-4.71%)

4.25

+0.02 (+0.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)05-14 2025-05-14
Inst Owners30.67%
Inst Owner Change0%
Ins Owners18.4%
Ins Owner Change-17.01%
Market Cap32.60M
AnalystsN/A
Price TargetN/A
Short Float %0.17%
Short Ratio0.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.74
P/FCF N/A
P/OCF N/A
P/B 3.44
P/tB 90.72
EV/EBITDA N/A
EPS(TTM)-0.64
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS2.44
BVpS1.24
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.9%
ROE -42.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.14%
FCFM N/A
ROA(3y)-7.91%
ROA(5y)-9.57%
ROE(3y)-13.61%
ROE(5y)-19.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.9%
GM growth 5Y-0.54%
F-Score2
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 89.11%
Cap/Sales 0.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.62
Altman-Z -1.39
F-Score2
WACC8.72%
ROIC/WACCN/A
Cap/Depr(3y)80.38%
Cap/Depr(5y)93.32%
Cap/Sales(3y)0.91%
Cap/Sales(5y)1.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.77%
Revenue growth 3Y21.43%
Revenue growth 5Y22.95%
Sales Q2Q%-6.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-70.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-629.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1108.21%
OCF growth 3YN/A
OCF growth 5YN/A